Chairman David 4
4 · Valens Semiconductor Ltd. · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
Valens Semiconductor (VLN) SVP David Exercises Options, Sells 4,000 Shares
What Happened
- David, SVP R&D at Valens Semiconductor, exercised stock options and sold the resulting shares on May 8, 2026. The filing shows he acquired 4,000 shares by exercising options at $0.86 per share (cost $3,440) and then sold 4,000 shares in an open-market sale at a weighted-average price of $2.54 per share (proceeds $10,172). A related derivative entry was reported at $0.00, reflecting the option disposition on exercise. Net proceeds before taxes and fees were roughly $6,732.
Key Details
- Transaction date: May 8, 2026; Form 4 filed May 11, 2026.
- Exercise: 4,000 shares, $0.86 per share, total $3,440 (code M = exercise/conversion of derivative).
- Sale: 4,000 shares, $2.54 weighted-average price, total $10,172 (code S = sale).
- Footnotes: sale was executed under a Rule 10b5-1 trading plan adopted Aug 16, 2024 (F1); shares sold were acquired upon exercise of options the same date (F2/F4/F5); reported sale price is a weighted average (F3).
- Shares owned after the transactions: not reported in the excerpt of the filing.
Context
- This was effectively a same-day exercise-and-sell (cashless-style) transaction: options were exercised to acquire shares and those shares were sold that same day. The presence of a 10b5-1 plan indicates the sale followed a pre-established trading schedule rather than an ad-hoc decision. The filing provides factual transaction details but does not indicate insider intent.
Insider Transaction Report
Form 4
Chairman David
SVP, R&D
Transactions
- Exercise/Conversion
Ordinary Shares
[F1][F5]2026-05-08$0.86/sh+4,000$3,440→ 407,968 total - Sale
Ordinary Shares
[F1][F2][F3]2026-05-08$2.54/sh−4,000$10,172→ 403,968 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-08−4,000→ 83,695 totalExercise: $0.86From: 2022-06-01Exp: 2031-06-09→ Ordinary Shares (4,000 underlying)
Footnotes (5)
- [F1]The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
- [F2]The shares sold were acquired upon the exercise of stock options on the same date
- [F3]The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
- [F4]The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
- [F5]The shares were acquired upon the exercise of stock options
Signature
David Chairman by: Oppenheimer Israel, as Attorney-in-fact|2026-05-11